Zurich Cantonal Bank’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.3K | Sell |
83
-14
| -14% | -$2.42K | ﹤0.01% | 2498 |
|
2025
Q1 | $15.1K | Sell |
97
-16
| -14% | -$2.49K | ﹤0.01% | 2568 |
|
2024
Q4 | $15.6K | Sell |
113
-26
| -19% | -$3.58K | ﹤0.01% | 2598 |
|
2024
Q3 | $20.8K | Hold |
139
| – | – | ﹤0.01% | 2597 |
|
2024
Q2 | $19K | Sell |
139
-3
| -2% | -$409 | ﹤0.01% | 2591 |
|
2024
Q1 | $21.5K | Buy |
142
+32
| +29% | +$4.84K | ﹤0.01% | 2622 |
|
2023
Q4 | $13.9K | Sell |
110
-14
| -11% | -$1.76K | ﹤0.01% | 2669 |
|
2023
Q3 | $11.6K | Sell |
124
-41
| -25% | -$3.84K | ﹤0.01% | 2733 |
|
2023
Q2 | $14.7K | Sell |
165
-40
| -20% | -$3.57K | ﹤0.01% | 2736 |
|
2023
Q1 | $22K | Buy |
+205
| New | +$22K | ﹤0.01% | 2738 |
|
2022
Q3 | – | Sell |
-4,093
| Closed | -$380K | – | 2906 |
|
2022
Q2 | $380K | Hold |
4,093
| – | – | ﹤0.01% | 1394 |
|
2022
Q1 | $480K | Hold |
4,093
| – | – | ﹤0.01% | 1343 |
|
2021
Q4 | $551K | Hold |
4,093
| – | – | ﹤0.01% | 1368 |
|
2021
Q3 | $652K | Hold |
4,093
| – | – | ﹤0.01% | 1126 |
|
2021
Q2 | $538K | Sell |
4,093
-744
| -15% | -$97.8K | ﹤0.01% | 1192 |
|
2021
Q1 | $623K | Hold |
4,837
| – | – | ﹤0.01% | 1087 |
|
2020
Q4 | $807K | Buy |
4,837
+785
| +19% | +$131K | ﹤0.01% | 1044 |
|
2020
Q3 | $625K | Hold |
4,052
| – | – | ﹤0.01% | 992 |
|
2020
Q2 | $599K | Buy |
4,052
+1,267
| +45% | +$187K | 0.01% | 945 |
|
2020
Q1 | $314K | Hold |
2,785
| – | – | ﹤0.01% | 1020 |
|
2019
Q4 | $387K | Buy |
+2,785
| New | +$387K | ﹤0.01% | 995 |
|